Metropolitan Life Insurance CO Bio Xcel Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$17.7 - $33.24 $5,133 - $9,639	-290 Reduced 22.22%	1,015 $18,000
Q4 2022 Jun 14, 2023	BUY	$10.25 - $22.43 $2,972 - $6,504	290 Added 28.57%	1,305 $28 Million
Q3 2022 Jun 14, 2023	BUY	$11.19 - $17.89 $3,245 - $5,188	290 Added 28.57%	1,305 $15.4 Million
Q2 2022 Jun 20, 2023	BUY	$9.03 - $21.55 $2,618 - $6,249	290 Added 28.57%	1,305 $17,000
Q1 2022 Jun 20, 2023	BUY	$15.0 - $22.83 $4,350 - $6,620	290 Added 28.57%	1,305 $27,000
Q1 2022 Mar 30, 2023	SELL	$15.0 - $22.83 $53,655 - $81,662	-3,577 Reduced 73.27%	1,305 $27,000
Q1 2022 May 12, 2022	SELL	$15.0 - $22.83 $53,655 - $81,662	-3,577 Reduced 73.27%	1,305 $27,000
Q4 2021 Jun 21, 2023	BUY	$20.12 - $35.09 $77,804 - $135,693	3,867 Added 380.99%	4,882 $99,000
Q3 2021 Jun 21, 2023	BUY	$23.84 - $32.03 $92,189 - $123,860	3,867 Added 380.99%	4,882 $148,000
Q3 2021 Mar 30, 2023	BUY	$23.84 - $32.03 $21,670 - $29,115	909 Added 22.88%	4,882 $148,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $21,670 - $29,115	909 Added 22.88%	4,882 $148,000
Q2 2021 Jun 21, 2023	BUY	$29.06 - $38.83 $85,959 - $114,859	2,958 Added 291.43%	3,973 $115,000
Q2 2021 Mar 30, 2023	BUY	$29.06 - $38.83 $16,622 - $22,210	572 Added 16.82%	3,973 $115,000
Q2 2021 Aug 16, 2021	BUY	$29.06 - $38.83 $115,368 - $154,155	3,970 Added 132333.33%	3,973 $115,000
Q1 2021 Jun 26, 2023	BUY	$39.04 - $64.6 $93,149 - $154,135	2,386 Added 235.07%	3,401 $147 Million
Q1 2021 May 14, 2021	SELL	$39.04 - $64.6 $132,657 - $219,510	-3,398 Reduced 99.91%	3 $147,000
Q4 2020 Jun 22, 2023	BUY	$42.46 - $56.58 $101,309 - $134,999	2,386 Added 235.07%	3,401 $157,000
Q3 2020 Jun 26, 2023	BUY	$37.44 - $64.63 $89,331 - $154,207	2,386 Added 235.07%	3,401 $147,000
Q2 2020 Jun 26, 2023	BUY	$17.62 - $58.71 $42,041 - $140,082	2,386 Added 235.07%	3,401 $180,000
Q2 2020 Mar 30, 2023	BUY	$17.62 - $58.71 $36,931 - $123,056	2,096 Added 160.61%	3,401 $180,000
Q2 2020 Aug 14, 2020	BUY	$17.62 - $58.71 $59,925 - $199,672	3,401 New	3,401 $180,000
Q1 2020 Jul 12, 2023	SELL	$12.26 - $41.14 $5,651 - $18,965	-461 Reduced 45.42%	554 $12.4 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

3.14M

Call Options Held

22.2K

Put Options Held

40.2K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $9.81M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account